Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/16/25 16:41 | 10/15/25 | BCAX | Health | Drug | Pharmaceutical Preparations | Cohlhepp Ryan | MA | DO | P,COO | 2 | S.dm | -1,139 | 18.08 | 0 | -63 | 203 | D | |||||||||||||||
10/15/25 18:00 | 10/13/25 | BCAX | Health | Drug | Pharmaceutical Preparations | Mazumdar Claire | MA | DO | CEO | 1 | S.dm | -467 | 18.88 | 0 | -25 | 310 | D | |||||||||||||||
10/10/25 17:23 | 10/9/25 | BCAX | Health | Drug | Pharmaceutical Preparations | Raben David | MA | O | Chief Me | 1 | S.d | -406 | 18.45 | 0 | -22 | 35 | D | |||||||||||||||
10/10/25 17:22 | 10/9/25 | BCAX | Health | Drug | Pharmaceutical Preparations | Hyep Ivan | MA | O | CFO | 2 | S.dm | -670 | 18.21 | 0 | -37 | 145 | D | |||||||||||||||
10/1/25 16:57 | 6/16/25 | BCAX | Health | Drug | Pharmaceutical Preparations | Meisner Lara | MA | O | GC | 4 | S.d | -1,867 | 12.91 | 0 | -145 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |